• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human ATP8B1 Polyclonal Antibody

The antibody against ATP8B1 was raised in rabbit using the Recombinant Human Phospholipid-transporting ATPase IC protein (217-330AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IF.

ADC-16120A

The antibody against ATP8B1 was raised in rabbit using the Recombinant Human Phospholipid-transporting ATPase IC protein (217-330AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IF.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-16120A ClonalityPolyclonal
Host SpeciesRabbitTarget NameATP8B1
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4
Purification Method>95%, Protein G purifiedConjugateNon-conjugated
ApplicationELISA, IFStorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Phospholipid-transporting ATPase IC protein (217-330AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDO43520
Background Information
  • Uniprot Id

    O43520

  • Target Species

    Human

  • Target Name

    ATP8B1

  • Target Full Name

    Phospholipid-transporting ATPase IC

  • Target Function

    Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of phospholipids, in particular phosphatidylcholines (PC), from the outer to the inner leaflet of the plasma membrane. May participate in the establishment of the canalicular membrane integrity by ensuring asymmetric distribution of phospholipids in the canicular membrane. Thus may have a role in the regulation of bile acids transport into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both and protect hepatocytes from bile salts. Involved in the microvillus formation in polarized epithelial cells; the function seems to be independent from its flippase activity. Participates in correct apical membrane localization of CDC42, CFTR and SLC10A2. Enables CDC42 clustering at the apical membrane during enterocyte polarization through the interaction between CDC42 polybasic region and negatively charged membrane lipids provided by ATP8B1. Together with TMEM30A is involved in uptake of the synthetic drug alkylphospholipid perifosine. Required for the preservation of cochlear hair cells in the inner ear. May act as cardiolipin transporter during inflammatory injury.

  • Target Involvement

    Cholestasis, progressive familial intrahepatic, 1 (PFIC1); Cholestasis, benign recurrent intrahepatic, 1 (BRIC1); Cholestasis of pregnancy, intrahepatic 1 (ICP1)

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein. Apical cell membrane. Cell projection, stereocilium. Endoplasmic reticulum. Golgi apparatus.

  • Target Protein Families

    Cation transport ATPase (P-type) (TC 3.A.3) family, Type IV subfamily

  • Target Tissue Specificity

    Found in most tissues except brain and skeletal muscle. Most abundant in pancreas and small intestine.

  • Target Synonyms

    AT8B1_HUMAN; ATP8B1; ATPase class I type 8B member 1; ATPase; aminophospholipid transporter; class I; type 8B; member 1; ATPIC; BRIC; E1-E2 ATPase; Familial intrahepatic cholestasis type 1; FIC1; OTTHUMP00000163615; PFIC; PFIC1; Phospholipid transporting ATPase IC; Probable phospholipid-transporting ATPase IC

Inquire Rabbit anti-Human ATP8B1 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification